Skip to main content
. Author manuscript; available in PMC: 2012 Aug 23.
Published in final edited form as: J Matern Fetal Neonatal Med. 2010 Aug;23(8):820–827. doi: 10.3109/14767050903366119

Table II.

Comparison of the maternal plasma and serum concentrations of sVEGFR-1, sVEGFR-2, PlGF and sEng in patients with a normal pregnancy

Analyte Plasma (n=70) Serum (n=70) p*
sVEGFR-1 (pg/mL) 2,081.8 (264.8–19,210.9) 2,288.6 (277.7–15,861.8) <0.001
sVEGFR-2 (pg/mL) 9,161.7 (6,201.1–13,817.8) 10,231.4 (6,379.4–16,168) <0.001
PlGF (pg/mL) 189.2 (6.8–1,896.3) 197.5 (6.8–1,841.8) 0.1
sEng (ng/mL) 8.6 (4.5–38.4) 8.4 (4.7–44.9) 0.7

The results are expressed as median (range)

*

Wilcoxon ranks test